Imidazole

Imidazole

SCHEMBL28835236

CC1(O)CCOC(=O)C1.c1c[nH]cn1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.63
CYP2C9 P11712 1/20 0.63
ALDH1A1 P00352 1/20 0.37
FKBP5 Q13451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1331223 0.79
SCHEMBL879 0.79
SCHEMBL880 0.79
SCHEMBL22905077 0.79
Water SCHEMBL23042869 0.78 LMNA (0.96) LMNACYP2C9ALDH1A1
Water SCHEMBL23042868 0.78 LMNA (0.96) LMNACYP2C9ALDH1A1
Butyrolactone SCHEMBL29053245 0.70 CA1 (0.47) LMNAALDH1A1FKBP5
SCHEMBL28787742 0.69 LMNA (0.76) LMNACYP2C9ALDH1A1
Imidazole SCHEMBL28248513 0.66 ALDH1A1 (0.54) ALDH1A1FKBP5
Imidazole SCHEMBL28866219 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106075451-A Use SGLT2 inhibitor and combinations thereof thing that the treatment previously carried out with other antidiabetic drug is had in the patient of tolerance the method treating type ii diabetes 阿斯利康(瑞典)有限公司 2016-11-09 CN disclosed